HPV Clinical Trials

Find clinical trials for HPV. Search for HPV clinical trials in different cities and states across the United States.

HPV

e.g. Massachusetts•Healthy volunteers: No

Filter results

Results: 106

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Recruiting

Phase 1

Sponsor:

Novartis Pharmaceuticals

Location:

Los Angeles, Fort Myers, Boston

Code:

NCT05462873

Conditions

Carcinoma, Non-Small-Cell Lung

Carcinoma, Renal Cell

Esophageal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

QEQ278

Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)

Recruiting

Phase 3

Sponsor:

Lisette Nixon

Location:

Redwood City, Orlando, Houston

Code:

NCT02215265

Conditions

Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cisplatin

Postoperative radiotherapy

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

Recruiting

Sponsor:

Milton S. Hershey Medical Center

Location:

Reading

Code:

NCT05092022

Conditions

Cervical Cancer Screening

Eligibility Criteria

Sex: Female

Age: 30 - 65

Healthy Volunteers: Not accepted

Interventions

Evalyn Self-Sampling Brush

The HPV 9-10 Trial: Early Initiation of HPV Vaccination

Recruiting

Sponsor:

University of Colorado, Denver

Location:

Los Angeles, Aurora

Code:

NCT04722822

Conditions

HPV

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

(Intervention) Recommending HPV vaccine for patients 9-10 years of age

(Control) Recommending HPV vaccine for patients 11-12 years of age

Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)

Recruiting

Phase 2

Sponsor:

UCLA

Location:

La Jolla

Code:

NCT05787639

Conditions

Oropharynx Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evorpacept

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

Recruiting

Phase 2

Sponsor:

University of Michigan Rogel Cancer Center

Location:

Ann Arbor

Code:

NCT06234748

Conditions

Oropharynx Cancer

HPV-Related Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Radiation

Platinum based chemotherapy

Provider Recommendation and HPV Vaccination

Recruiting

Sponsor:

Kaiser Permanente

Location:

Pasadena

Code:

NCT05365048

Conditions

Human Papillomavirus

Eligibility Criteria

Sex: All

Age: 21 - 70

Healthy Volunteers: Not accepted

Interventions

Local Tailoring implementation strategy

Prescribed Strategy

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Marengo Therapeutics, Inc.

Location:

Celebration, Miami, Bethesda, Bostonshow 2 more

Code:

NCT05592626

Conditions

Advanced Solid Tumors

Genital Neoplasm, Female

Urogenital Neoplasms

Lung Neoplasm

Neoplasms by Site

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

STAR0602

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV

Recruiting

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Cincinnati

Code:

NCT01709448

Conditions

Neoplasms, Squamous Cell

Papillomavirus Infections

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

Recruiting

Early Phase 1

Sponsor:

Washington University School of Medicine

Location:

Saint Louis

Code:

NCT05678348

Conditions

Head and Neck Cancer

Cancer of the Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pyrimethamine

HPV

e.g. Massachusetts•Healthy volunteers: No

Filter results

Results: 106

A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors

Recruiting

Phase 1

Sponsor:

Novartis Pharmaceuticals

Location:

Los Angeles, Fort Myers, Boston

Code:

NCT05462873

Conditions

Carcinoma, Non-Small-Cell Lung

Carcinoma, Renal Cell

Esophageal Squamous Cell Carcinoma

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

QEQ278

Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)

Recruiting

Phase 3

Sponsor:

Lisette Nixon

Location:

Redwood City, Orlando, Houston

Code:

NCT02215265

Conditions

Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cisplatin

Postoperative radiotherapy

St. Joseph's HPV Self-sampling: Offering a Self-sampling Option in Clinic

Recruiting

Sponsor:

Milton S. Hershey Medical Center

Location:

Reading

Code:

NCT05092022

Conditions

Cervical Cancer Screening

Eligibility Criteria

Sex: Female

Age: 30 - 65

Healthy Volunteers: Not accepted

Interventions

Evalyn Self-Sampling Brush

The HPV 9-10 Trial: Early Initiation of HPV Vaccination

Recruiting

Sponsor:

University of Colorado, Denver

Location:

Los Angeles, Aurora

Code:

NCT04722822

Conditions

HPV

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

(Intervention) Recommending HPV vaccine for patients 9-10 years of age

(Control) Recommending HPV vaccine for patients 11-12 years of age

Neoadjuvant Immunoradiotherapy With Evorpacept and Pembrolizumab in HPVOPC (Human Papilloma Virus Oropharynx Cancer)

Recruiting

Phase 2

Sponsor:

UCLA

Location:

La Jolla

Code:

NCT05787639

Conditions

Oropharynx Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Evorpacept

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

Recruiting

Phase 2

Sponsor:

University of Michigan Rogel Cancer Center

Location:

Ann Arbor

Code:

NCT06234748

Conditions

Oropharynx Cancer

HPV-Related Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Radiation

Platinum based chemotherapy

Provider Recommendation and HPV Vaccination

Recruiting

Sponsor:

Kaiser Permanente

Location:

Pasadena

Code:

NCT05365048

Conditions

Human Papillomavirus

Eligibility Criteria

Sex: All

Age: 21 - 70

Healthy Volunteers: Not accepted

Interventions

Local Tailoring implementation strategy

Prescribed Strategy

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Marengo Therapeutics, Inc.

Location:

Celebration, Miami, Bethesda, Bostonshow 2 more

Code:

NCT05592626

Conditions

Advanced Solid Tumors

Genital Neoplasm, Female

Urogenital Neoplasms

Lung Neoplasm

Neoplasms by Site

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

STAR0602

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV

Recruiting

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Location:

Cincinnati

Code:

NCT01709448

Conditions

Neoplasms, Squamous Cell

Papillomavirus Infections

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma

Recruiting

Early Phase 1

Sponsor:

Washington University School of Medicine

Location:

Saint Louis

Code:

NCT05678348

Conditions

Head and Neck Cancer

Cancer of the Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pyrimethamine